ProKidney Corp (PROK)
NASDAQ · Healthcare
ProKidney Corp Revenue 2022–2025
ProKidney Corp annual/quarterly revenue history and growth rate from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- ProKidney Corp revenue for the quarter ending March 31, 2026 was 226000, a 1.74% decrease year-over-year.
- ProKidney Corp revenue for the twelve months ending March 31, 2026 was 894000.
- ProKidney Corp annual revenue for 2025 was 893000, a 1075.00% increase from 2024.
- ProKidney Corp annual revenue for 2024 was 76000.
- ProKidney Corp annual revenue for 2023 was 0.
- ProKidney Corp annual revenue for 2022 was 0.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
ProKidney Corp (PROK) — Frequently Asked Questions
ProKidney Corp (PROK) is a publicly traded US company. In fiscal 2025 it reported revenue of $893,000 and net income of -$69M. Explore PROK's stock price, financial statements, earnings history, margins and key ratios below.
What is the PROK stock price?
PROK trades at $1.67.
How much revenue does ProKidney Corp make?
ProKidney Corp reported revenue of $893,000 in fiscal 2025.
Is PROK profitable?
In fiscal 2025, ProKidney Corp reported net income of -$69M.